LEGEND BIOTECH CORPORATION

Transcripts Legend Biotech Corporation

Equities

LEGN

US52490G1022

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
45.57 ^USD	-2.13%		+13.90%	-24.26%

Jun. 03	Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses	MT
Jun. 03	Legend Biotech Corporation Shares Data on the Earlier Use to Date of CARVYKTI in the Treatment of Multiple Myeloma and Important Subgroup Analyses At ASCO and EHA	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Legend Biotech Corporation, Q1 2024 Earnings Call, May 13, 2024	May. 13
Transcript : Legend Biotech Corporation, Q4 2023 Earnings Call, Mar 11, 2024	Mar. 11
Transcript : Legend Biotech Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 02:15 PM	Jan. 09
Transcript : Legend Biotech Corporation, Q3 2023 Earnings Call, Nov 20, 2023	Nov. 20
Transcript : Legend Biotech Corporation, Q2 2023 Earnings Call, Aug 15, 2023	23-08-15
Transcript : Legend Biotech Corporation Presents at 2023 American Society of Clinical Oncology Annual Meeting, Jun-02-2023 through Jun-06-2023	23-06-05
Transcript : Legend Biotech Corporation - Special Call	22-10-03
Legend Biotech Corporation Provides Earnings Guidance for the Six Months Ended June 30, 2022	22-08-05	CI
Legend Biotech Corporation Provides Earnings Guidance for the Year Ended December 31, 2021	22-02-18	CI
Transcript : Legend Biotech Corporation Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 02:15 PM	22-01-11
Transcript : Legend Biotech Corporation - Special Call	21-12-13
Transcript : Legend Biotech Corporation - Special Call	21-10-18
Transcript : Legend Biotech Corporation Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-10-2021 08:45 AM	21-09-10
Transcript : Legend Biotech Corporation, Q4 2020 Earnings Call, Mar 18, 2021	21-03-18
Legend Biotech Corporation Provides Earnings Guidance for the Year Ended December 31, 2020	21-02-19	CI
Transcript : Legend Biotech Corporation Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 01:30 PM	21-01-13
Transcript : Legend Biotech Corporation - Special Call	20-12-07
Legend Biotech Corporation Provides Earnings Guidance for the Six Months Ended June 30, 2020	20-08-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer